Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have been diagnosed with primary aldosteronism (a hormonal condition affecting the adrenal glands) following proper testing, and whose specific type has been identified as either an aldosterone-producing growth or generalised overactivity of both adrenal glands
- People whose blood pressure readings meet at least one of these conditions: a clinic reading of 140/90 mmHg or higher; or a 24-hour blood pressure monitor showing an average above 130/80 mmHg, or daytime readings above 135/85 mmHg
- People whose adrenal gland scan shows either enlargement, nodule formations, or no notable changes in appearance
- People who have had high blood pressure for more than 6 months
- People (or their legal guardians) who have signed a consent form approved by an ethics committee before any screening takes place
Who may not be able to join:
- People whose high blood pressure is caused by other conditions rather than primary aldosteronism
- Women who are currently pregnant, breastfeeding, or planning to become pregnant within the next year
- People who have significant disease affecting major organs, particularly the liver or kidneys
- People who have had a severe allergic reaction to contrast dye (the substance sometimes used in medical imaging)
- People with a serious illness where life expectancy is estimated to be less than 12 months
- People who are already enrolled in, or planning to join, another clinical trial that could affect this study's results
- People whom the trial researcher considers unsuitable for inclusion, for any reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peijian Wang, PhD, First Affiliated Hospital of Chengdu Medical College
Phone: 028-83016145
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Invasive blood pressure; 24-hour dynamic blood pressure; Plasma Norepinephrine; Plasma Adrenaline; Plasma Dopamin; Plasma Renin; Plasma Aldosterone; Serum sodium; Serum potassium
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.